Deferasirox
ATC Code
V03AC03
Deferasirox
Definition
A synthetic, orally bioavailable, achiral, tridentate triazole derived from salicylic acid with iron-chelating activity. Deferasirox chelates iron at a 2:1 (ligand:iron) ratio. Because of its oral availability and long plasma half-life, this agent may be superior to desferrioxamine (desferal, DFO), which is orally inactive and has a short plasma half-life.
Also known as 4-(3,5-Bis-(hydroxy-phenyl)-1,2,4-triazol-1-yl)-benzoic Acid, DEFERASIROX, Exjade, Jadenu — per NCIT
Also identified as
- ATC V03AC03 per RXNORM
- NCIT NCIT:C48384 per NCIT
- SCTID 417910004 per RXNORM
- SCTID 419985007 per RXNORM
- UNII V8G4MOF2V9 per RXNORM